Sunwin Stevia International Inc. (SUWN)
| Market Cap | 11.58M |
| Revenue (ttm) | 25.30M |
| Net Income (ttm) | -2.16M |
| Shares Out | 199.63M |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | July 23 |
| Last Price | $0.0598 |
| Previous Close | $0.0600 |
| Change ($) | -0.0002 |
| Change (%) | -0.33% |
| Day's Open | 0.0530 |
| Day's Range | 0.0530 - 0.0598 |
| Day's Volume | 4,334 |
| 52-Week Range | 0.0300 - 0.1500 |
News
There are no news available yet.
About SUWN
Sunwin Stevia International, Inc. produces and sells natural sweeteners and other pharmaceutical products primarily in the People's Republic of China. It operates through two segments, Stevioside; and Corporate and Other Pharmaceutical. The company produces and sells various steviol glycosides with rebaudioside A and stevioside as the principal components. It provides Steviosin, a low calorie stevia extract for medicinal use; and OnlySweet, a zero calorie tabletop sweetener to food and drug manufacturers, and ingredient distributor foreign trad... [Read more...]
| Industry Farm Products | |
| CEO Dongdong Lin | Employees 249 |
| Stock Exchange OTCMKTS | Ticker Symbol SUWN |
Financial Performance
In 2020, SUWN's revenue was $26.09 million, an increase of 25.14% compared to the previous year's $20.85 million. Losses were -$1.38 million, -71.83% less than in 2019.